| Full Name | Tom Noff |
|---|---|
| Gender | Male |
| Speciality | Neurology |
| Experience | 13 Years |
| Location | 3 Cooper Plz Rm 215, Camden, New Jersey |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1346582277 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084N0600X | Psychiatry & Neurology - Clinical Neurophysiology | 25MA10334700 (New Jersey) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Cooper University Hospital | Camden, NJ | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Cmc Department Of Medicine Group Pa | 2163335878 | 329 |
News Archive
Life Technologies Corporation today announced the publication of two key scientific papers that highlight the utility of next-generation sequencing instruments in better understanding disease and the genetic differences that cause diversity within and between human populations. The Applied Biosystems SOLiD™ System was used in both of these research studies.
Among women with a family history of breast cancer, those diagnosed with breast cancer gained weight at a greater rate compared with cancer-free women of the same age and menopausal status.
Now, a team of scientists at the United Kingdom's Rosalind Franklin Institute may have a surprising solution for the coronavirus pandemic, which has killed more than 574,000 people worldwide.
A study published this week by ITG revealed that Novartis recently approved drug, Gilenya, has already taken share from market leaders in the multiple sclerosis (MS) market, and uptake is expected to increase significantly over the next year. Gilenya came onto the market in late September as the first FDA-approved oral disease-modifying MS drug, and Novartis initially faced safety concerns and monitoring requirements that deterred some physicians from adopting the new drug.
Geisinger Health System, in central Pennsylvania, has been widely hailed as a model for health reform by leading Democrats including President Obama, the Philadelphia Inquirer reports. But, its success may hinge on "a rare combination of factors" including "a relative lack of competition, its stable patient base, and the fact that its 800 doctors are on salary," as well as an in-house pharmacy and insurance plan that covers one-third of its patients.
› Verified 2 days ago
| Entity Name | Cmc Department Of Medicine Group Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1386682094 PECOS PAC ID: 2163335878 Enrollment ID: O20050104000343 |
News Archive
Life Technologies Corporation today announced the publication of two key scientific papers that highlight the utility of next-generation sequencing instruments in better understanding disease and the genetic differences that cause diversity within and between human populations. The Applied Biosystems SOLiD™ System was used in both of these research studies.
Among women with a family history of breast cancer, those diagnosed with breast cancer gained weight at a greater rate compared with cancer-free women of the same age and menopausal status.
Now, a team of scientists at the United Kingdom's Rosalind Franklin Institute may have a surprising solution for the coronavirus pandemic, which has killed more than 574,000 people worldwide.
A study published this week by ITG revealed that Novartis recently approved drug, Gilenya, has already taken share from market leaders in the multiple sclerosis (MS) market, and uptake is expected to increase significantly over the next year. Gilenya came onto the market in late September as the first FDA-approved oral disease-modifying MS drug, and Novartis initially faced safety concerns and monitoring requirements that deterred some physicians from adopting the new drug.
Geisinger Health System, in central Pennsylvania, has been widely hailed as a model for health reform by leading Democrats including President Obama, the Philadelphia Inquirer reports. But, its success may hinge on "a rare combination of factors" including "a relative lack of competition, its stable patient base, and the fact that its 800 doctors are on salary," as well as an in-house pharmacy and insurance plan that covers one-third of its patients.
› Verified 2 days ago
| Entity Name | Inspira Health Network Medical Group Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1922177856 PECOS PAC ID: 4880797570 Enrollment ID: O20070319000280 |
News Archive
Life Technologies Corporation today announced the publication of two key scientific papers that highlight the utility of next-generation sequencing instruments in better understanding disease and the genetic differences that cause diversity within and between human populations. The Applied Biosystems SOLiD™ System was used in both of these research studies.
Among women with a family history of breast cancer, those diagnosed with breast cancer gained weight at a greater rate compared with cancer-free women of the same age and menopausal status.
Now, a team of scientists at the United Kingdom's Rosalind Franklin Institute may have a surprising solution for the coronavirus pandemic, which has killed more than 574,000 people worldwide.
A study published this week by ITG revealed that Novartis recently approved drug, Gilenya, has already taken share from market leaders in the multiple sclerosis (MS) market, and uptake is expected to increase significantly over the next year. Gilenya came onto the market in late September as the first FDA-approved oral disease-modifying MS drug, and Novartis initially faced safety concerns and monitoring requirements that deterred some physicians from adopting the new drug.
Geisinger Health System, in central Pennsylvania, has been widely hailed as a model for health reform by leading Democrats including President Obama, the Philadelphia Inquirer reports. But, its success may hinge on "a rare combination of factors" including "a relative lack of competition, its stable patient base, and the fact that its 800 doctors are on salary," as well as an in-house pharmacy and insurance plan that covers one-third of its patients.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Tom Noff, MD 1 Federal St Ste Sw200, Camden, NJ 08103-1155 Ph: (856) 356-4924 | Tom Noff, MD 3 Cooper Plz Rm 215, Camden, NJ 08103 Ph: (856) 342-2439 |
News Archive
Life Technologies Corporation today announced the publication of two key scientific papers that highlight the utility of next-generation sequencing instruments in better understanding disease and the genetic differences that cause diversity within and between human populations. The Applied Biosystems SOLiD™ System was used in both of these research studies.
Among women with a family history of breast cancer, those diagnosed with breast cancer gained weight at a greater rate compared with cancer-free women of the same age and menopausal status.
Now, a team of scientists at the United Kingdom's Rosalind Franklin Institute may have a surprising solution for the coronavirus pandemic, which has killed more than 574,000 people worldwide.
A study published this week by ITG revealed that Novartis recently approved drug, Gilenya, has already taken share from market leaders in the multiple sclerosis (MS) market, and uptake is expected to increase significantly over the next year. Gilenya came onto the market in late September as the first FDA-approved oral disease-modifying MS drug, and Novartis initially faced safety concerns and monitoring requirements that deterred some physicians from adopting the new drug.
Geisinger Health System, in central Pennsylvania, has been widely hailed as a model for health reform by leading Democrats including President Obama, the Philadelphia Inquirer reports. But, its success may hinge on "a rare combination of factors" including "a relative lack of competition, its stable patient base, and the fact that its 800 doctors are on salary," as well as an in-house pharmacy and insurance plan that covers one-third of its patients.
› Verified 2 days ago
Dr. Thomas Denton Demark, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 3 Cooper Plz, Suite 307, Camden, NJ 08103 Phone: 856-342-2328 Fax: 856-541-6137 | |
Nicholas Matthew Adamo, MD Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 1 Cooper Plz, Camden, NJ 08103 Phone: 800-826-6737 | |
Pamela Szeeley, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 3 Cooper Plz, Suite 307, Camden, NJ 08103 Phone: 856-968-7433 | |
John E Bevilacqua, MD Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 3 Cooper Plz, Suite 320, Camden, NJ 08103 Phone: 856-616-1337 | |
Dr. Michael H Goodman, MD Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 3 Cooper Plz, Suite 200, Camden, NJ 08103 Phone: 856-342-2001 Fax: 856-968-2499 | |
Yingcheng Xu, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 3 Cooper Plz Rm 307, Camden, NJ 08103 Phone: 856-342-2328 | |
Teresa J Humaran, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 3 Cooper Plz, Suite 307, Camden, NJ 08103 Phone: 856-342-2328 Fax: 856-541-6137 |